Literature DB >> 15489002

Characterization of vitamin D-mediated induction of the CYP 24 transcription.

Katsuhisa Tashiro1, Takaya Abe, Naohide Oue, Wataru Yasui, Masaru Ryoji.   

Abstract

Transcription of the CYP24 (25-hydroxyvitamin D(3)-24-hydroxylase) gene is known to be induced by 1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3). We studied the induction kinetics in detail in human skin-derived fibroblasts. While the basal transcription of this gene was very low, addition of 1,25(OH)2D3 increased the mRNA level by 50-fold within 1h. The induction reached as high as 20000-fold after 12h. DNA microarray analysis also indicated that the induction ratio of the CYP24 gene is exceptionally high among 3800 human genes examined. The increase of mRNA was caused by stimulation of the transcription, but not by stabilization of mRNA. 24(R),25-dihydroxyvitamin D3 (24,25(OH)2D3), a compound metabolically related to 1,25(OH)2D3, also stimulated the CYP24 gene transcription, though at much higher concentrations. However, this stimulation was significantly augmented by synergistic actions of 24,25(OH)2D3 and 1,25(OH)2D3, suggesting that 24,25(OH)2D3 or its metabolites might be playing some roles in the regulation of CYP24 gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489002     DOI: 10.1016/j.mce.2004.07.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.

Authors:  Xiaolong Zhou; Sikandar G Khan; Deborah Tamura; Takahiro Ueda; Jennifer Boyle; Emmanuel Compe; Jean-Marc Egly; John J DiGiovanna; Kenneth H Kraemer
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

3.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

4.  Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification.

Authors:  Haiqing Shen; Lawrence F Bielak; Jane F Ferguson; Elizabeth A Streeten; Laura M Yerges-Armstrong; Jie Liu; Wendy Post; Jeffery R O'Connell; James E Hixson; Sharon L R Kardia; Yan V Sun; Min A Jhun; Xuexia Wang; Nehal N Mehta; Mingyao Li; Daniel L Koller; Hakan Hakonarson; Brendan J Keating; Daniel J Rader; Alan R Shuldiner; Patricia A Peyser; Muredach P Reilly; Braxton D Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

5.  CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.

Authors:  János P Kósa; Péter Horváth; János Wölfling; Dóra Kovács; Bernadett Balla; Péter Mátyus; Evelin Horváth; Gábor Speer; István Takács; Zsolt Nagy; Henrik Horváth; Péter Lakatos
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

6.  Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.

Authors:  Min Cui; Yan Zhao; Kenneth W Hance; Andrew Shao; Richard J Wood; James C Fleet
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

7.  Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.

Authors:  Giuseppe Viccica; Filomena Cetani; Edda Vignali; Mario Miccoli; Claudio Marcocci
Journal:  Endocrine       Date:  2016-03-31       Impact factor: 3.633

8.  Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.

Authors:  Elizabeth A Streeten; Amy S Rogstad; Kristin M Flammer; Kiarash Zarbalian; Kathleen Ryan; Mara Horwitz; Michael F Holick; John Shelton
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

9.  1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.

Authors:  Monika H E Christensen; Ellen M Apalset; Yngve Nordbø; Jan Erik Varhaug; Gunnar Mellgren; Ernst A Lien
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Parathyroid Hormone Gene and Genes Involved in the Maintenance of Vitamin D Levels Association with Mandibular Retrognathism.

Authors:  Erika Calvano Küchler; Caio Luiz Bitencourt Reis; Guido Marañón-Vásquez; Paulo Nelson-Filho; Mírian Aiko Nakane Matsumoto; Maria Bernadete Sasso Stuani; Maria Angélica Hueb de Menezes Oliveira; Peter Proff; Christian Kirschneck
Journal:  J Pers Med       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.